Leishmaniasis in Sudan 1. Cutaneous leishmaniasis

被引:28
作者
El-Hassan, AM
Zijlstra, EE
机构
[1] Univ Khartoum, Inst Endem Dis, Dept Immunol & Clin Pathol, Khartoum, Sudan
[2] Univ Khartoum, Inst Endem Dis, Dept Epidemiol & Clin Sci, Khartoum, Sudan
关键词
leishmaniasis; cutaneous leishmaniasis; Leishmania major; Phlebotomus papatasi; clinical features; diagnosis; epidemiology; history; pathology; treatment; Sudan;
D O I
10.1016/S0035-9203(01)90216-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cutaneous leishmaniasis (CL) in Sudan is caused by Leishmania major, zymodeme LON-1. The disease is endemic in many parts of the country. The vector is Phlebotomus papatasi and the animal reservoir is probably the Nile rat Arvicanthis niloticus. Clinically, patients usually present with papules, nodules, or noduloulcerative lesions, mainly on the exposed parts of the skin. In 20% of cases the parasite disseminates through the lymphatics, producing sporotrichoid-like lesions. The pathology of the lesion is described. Langerhans cells are the main antigen-presenting cells in CL. They pick up antigen from the dermis and migrate to regional lymph nodes where they present it to T cells. Antigen-specific activated T cells home to the dermis where they stimulate macrophages to eliminate the parasite. Peripheral blood mononuclear cells (PBMC) proliferate in response to Leishmania antigen in vitro and produce cytokines. PBMC of patients with mild and severe disease produce Th-1- and Th-2- like cytokine patterns, respectively. The criteria for the clinical diagnosis of CL are described. The diagnosis is confirmed by the demonstration of parasites in slit smears in 50-70% of cases and in histological sections in 70%. With primers specific for L. major, the polymerase chain reaction is positive in 86% of cases. Since CL is a self-limiting disease, treatment is confined to patients with severe disease.
引用
收藏
页码:S1 / S17
页数:17
相关论文
共 73 条
[21]  
ElHassan AM, 1987, SUDAN MED J, P11
[22]   TOPICAL TREATMENT OF OLD-WORLD CUTANEOUS LEISHMANIASIS CAUSED BY LEISHMANIA-MAJOR - A DOUBLE-BLIND CONTROL STUDY [J].
ELON, J ;
HALEVY, S ;
GRUNWALD, MH ;
WEINRAUCH, L .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (02) :227-231
[23]   STUDIES ON THE LEISHMANIASES IN THE SUDAN .1. EPIDEMIC OF CUTANEOUS LEISHMANIASIS IN KHARTOUM [J].
ELSAFI, SH ;
PETERS, W .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1991, 85 (01) :44-47
[24]   STUDIES ON THE LEISHMANIASES IN THE SUDAN .2. CLINICAL AND PARASITOLOGICAL STUDIES ON CUTANEOUS LEISHMANIASIS [J].
ELSAFI, SH ;
PETERS, W ;
ELTOAM, B ;
ELKADAROW, A ;
EVANS, DA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1991, 85 (04) :457-464
[25]  
ELSAYED S, 1990, THESIS U KHARTOUM
[26]   Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major [J].
Gaafar, A ;
Veress, B ;
Permin, H ;
Kharazmi, A ;
Theander, TG ;
El Hassan, AM .
CLINICAL IMMUNOLOGY, 1999, 91 (03) :314-320
[27]   THE PATHOLOGY OF CUTANEOUS LEISHMANIASIS DUE TO LEISHMANIA-MAJOR IN SUDAN [J].
GAAFAR, A ;
ELKADARO, AY ;
THEANDER, TG ;
PERMIN, H ;
ISMAIL, A ;
KHARAZMI, A ;
ELHASSAN, AM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (05) :438-442
[28]  
Gaafar A, 1996, TROP MED INT HEALTH, V1, P243
[29]   SPOROTRICHOID CUTANEOUS LEISHMANIASIS DUE TO LEISHMANIA-MAJOR OF DIFFERENT ZYMODEMES IN THE SUDAN AND SAUDI-ARABIA - A COMPARATIVE-STUDY [J].
GAAFAR, A ;
FADL, A ;
ELKADARO, AY ;
ELHASSAN, MM ;
KEMP, M ;
ISMAIL, AIA ;
MORGOS, SA ;
ELHASSAN, AM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (05) :552-554
[30]  
GAAFAR A, 1995, CLIN EXP IMMUNOL, V100, P239